T. Rowe Price Associates’s CVS Health CVS Stock Holding History

T. Rowe Price Associates’s Portfolio CVS Stock Details CVS Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$1.15B	Buy	16,613,144 +1,303,855	+9%	+$89.9M	0.13%	151
2025 Q1	$1.04B	Buy	15,309,289 +1,942,886	+15%	+$132M	0.13%	157
2024 Q4	$600M	Buy	13,366,403 +1,660,321	+14%	+$74.5M	0.07%	243
2024 Q3	$736M	Buy	11,706,082 +1,469,710	+14%	+$92.4M	0.08%	219
2024 Q2	$605M	Sell	10,236,372 -462,662	-4%	-$27.3M	0.07%	236
2024 Q1	$853M	Buy	10,699,034 +13,268	+0.1%	+$1.06M	0.1%	182
2023 Q4	$844M	Sell	10,685,766 -21,271	-0.2%	-$1.68M	0.11%	180
2023 Q3	$748M	Buy	10,707,037 +942,795	+10%	+$65.8M	0.11%	189
2023 Q2	$675M	Buy	9,764,242 +857,471	+10%	+$59.3M	0.09%	206
2023 Q1	$662M	Sell	8,906,771 -1,708,750	-16%	-$127M	0.1%	203
2022 Q4	$989M	Buy	10,615,521 +1,006,358	+10%	+$93.8M	0.16%	137
2022 Q3	$916M	Sell	9,609,163 -202,085	-2%	-$19.3M	0.15%	140
2022 Q2	$909M	Sell	9,811,248 -384,640	-4%	-$35.6M	0.11%	193
2022 Q1	$1.03B	Sell	10,195,888 -291,416	-3%	-$29.5M	0.1%	201
2021 Q4	$1.08B	Sell	10,487,304 -137,315	-1%	-$14.2M	0.1%	207
2021 Q3	$902M	Sell	10,624,619 -2,314,962	-18%	-$196M	0.08%	244
2021 Q2	$1.08B	Buy	12,939,581 +903,835	+8%	+$75.4M	0.1%	211
2021 Q1	$905M	Sell	12,035,746 -1,872,247	-13%	-$141M	0.09%	238
2020 Q4	$950M	Sell	13,907,993 -3,326,130	-19%	-$227M	0.1%	217
2020 Q3	$1.01B	Sell	17,234,123 -3,976,762	-19%	-$232M	0.12%	186
2020 Q2	$1.38B	Buy	21,210,885 +1,780,972	+9%	+$116M	0.17%	123
2020 Q1	$1.15B	Buy	19,429,913 +312,203	+2%	+$18.5M	0.18%	122
2019 Q4	$1.42B	Sell	19,117,710 -73,790	-0.4%	-$5.48M	0.18%	120
2019 Q3	$1.21B	Buy	19,191,500 +544,992	+3%	+$34.4M	0.17%	137
2019 Q2	$1.02B	Sell	18,646,508 -5,969,039	-24%	-$325M	0.14%	160
2019 Q1	$1.33B	Buy	24,615,547 +1,582,706	+7%	+$85.4M	0.2%	119
2018 Q4	$1.51B	Buy	23,032,841 +1,882,778	+9%	+$123M	0.26%	99
2018 Q3	$1.66B	Sell	21,150,063 -2,259,808	-10%	-$178M	0.24%	97
2018 Q2	$1.51B	Buy	23,409,871 +2,725,971	+13%	+$175M	0.23%	106
2018 Q1	$1.29B	Buy	20,683,900 +5,597,820	+37%	+$348M	0.2%	111
2017 Q4	$1.09B	Buy	15,086,080 +6,320,630	+72%	+$458M	0.18%	128
2017 Q3	$713M	Buy	8,765,450 +458,135	+6%	+$37.3M	0.12%	182
2017 Q2	$668M	Buy	8,307,315 +985,144	+13%	+$79.3M	0.12%	199
2017 Q1	$575M	Sell	7,322,171 -222,033	-3%	-$17.4M	0.11%	220
2016 Q4	$595M	Sell	7,544,204 -6,855,888	-48%	-$541M	0.12%	204
2016 Q3	$1.28B	Buy	14,400,092 +4,699,619	+48%	+$418M	0.26%	92
2016 Q2	$929M	Sell	9,700,473 -7,147,975	-42%	-$684M	0.2%	130
2016 Q1	$1.75B	Sell	16,848,448 -1,755,958	-9%	-$182M	0.37%	56
2015 Q4	$1.82B	Sell	18,604,406 -3,375,033	-15%	-$330M	0.38%	61
2015 Q3	$2.12B	Buy	21,979,439 +1,899,084	+9%	+$183M	0.47%	43
2015 Q2	$2.11B	Buy	20,080,355 +1,691,641	+9%	+$177M	0.43%	48
2015 Q1	$1.9B	Sell	18,388,714 -499,374	-3%	-$51.5M	0.39%	56
2014 Q4	$1.82B	Sell	18,888,088 -2,133,178	-10%	-$205M	0.39%	52
2014 Q3	$1.67B	Buy	21,021,266 +593,131	+3%	+$47.2M	0.37%	60
2014 Q2	$1.54B	Buy	20,428,135 +2,514,316	+14%	+$190M	0.33%	69
2014 Q1	$1.34B	Buy	17,913,819 +1,795,447	+11%	+$134M	0.3%	78
2013 Q4	$1.15B	Buy	16,118,372 +156,689	+1%	+$11.2M	0.26%	91
2013 Q3	$906M	Sell	15,961,683 -355,416	-2%	-$20.2M	0.23%	114
2013 Q2	$933M	Buy	+16,317,099	New	+$933M	0.25%	101